Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988–2014
There is controversy over the usefulness of prediabetes as a diagnostic label. Using data from US National Health and Nutrition Examination Surveys (NHANES) between 1988 and 2014, we examined the cardiovascular and renal burdens in adults with prediabetes over time and compared patterns with other g...
Gespeichert in:
Veröffentlicht in: | The lancet. Diabetes & endocrinology 2018-05, Vol.6 (5), p.392-403 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | There is controversy over the usefulness of prediabetes as a diagnostic label. Using data from US National Health and Nutrition Examination Surveys (NHANES) between 1988 and 2014, we examined the cardiovascular and renal burdens in adults with prediabetes over time and compared patterns with other glycaemic status groups.
We analysed cross-sectional survey data from non-pregnant adults aged 20 years and older from the NHANES survey periods 1988–94, 1999–2004, 2005–10, and 2011–14. We defined diagnosed diabetes as patients' self-report that they had been previously diagnosed by a physician or health professional; among those with no self-reported diabetes, prediabetes was defined as a fasting plasma glucose (FPG) concentration of 100–125 mg/dL (5·6–6·9 mmol/L) or an HbA1c of 5·7–6·4% (39–47 mmol/mol); undiagnosed diabetes as an FPG of 126 mg/dL (7·0 mmol/L) or higher or an HbA1c of 6·5% (48 mmol/mol) or higher; and normal glycaemic status as an FPG of less than 100 mg/dL (5·6 mmol/L) and an HbA1c of less than 5·7% (39 mmol/mol). We repeated the analyses using varying definitions of prediabetes (FPG 110–125 mg/dL [6·1–6·9 mmol/L] or HbA1c 5·7–6·4% [39–47 mmol/mol], FPG 110–125 mg/dL [6·1–6·9 mmol/L] or HbA1c 6·0–6·4% [42–47 mmol/mol], and FPG 100–125 mg/dL [5·6–6·9 mmol/L] and HbA1c 5·7–6·4% [39–47 mmol/mol]). For each group over time, we estimated the prevalences of hypertension and dyslipidaemia; and among individuals with those conditions, we estimated the proportions who had been treated and who were achieving care goals. By glycaemic group, we estimated those who were current, former, and never smokers; mean 10-year risk of cardiovascular disease (using estimators from the Framingham Heart Study, the United Kingdom Prospective Diabetes Study (UKPDS), and the ACC/AHA ASCVD guidelines); albuminuria (median and albumin-to-creatinine ratio ≥30 mg/g), estimated glomerular filtration rate (eGFR; mean and |
---|---|
ISSN: | 2213-8587 2213-8595 2213-8595 |
DOI: | 10.1016/S2213-8587(18)30027-5 |